BD's $35 Million Investment in Nebraska to Boost Syringe Manufacturing Capacity BD announces a major investment of $35 million in Nebraska to expand its prefilled flush syringe manufacturing, enhancing U.S. healthcare support.

BD's $35 Million Investment in Nebraska to Boost Syringe Manufacturing Capacity #United_States #Columbus #Becton_Dickinson #Healthcare_Support #Prefilled_Syringe